Ionis Pharmaceuticals Inc. Stock
There is nearly no change for the Ionis Pharmaceuticals Inc. stock today. Compared to yesterday it only changed by €0.040.
With 52 Buy predictions and 1 Sell predictions Ionis Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 76 € shows a positive potential of 20.83% compared to the current price of 62.9 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 0.060% | 0.576% | -8.287% | 111.223% | -7.504% | 93.564% | 72.196% |
| United Therapeutics | 2.240% | 1.319% | 3.012% | 59.768% | 9.665% | 129.369% | 237.122% |
| Ligand Pharmaceuticals | 2.300% | -3.279% | 10.625% | 75.248% | 6.627% | 182.207% | 35.632% |
| Novocure Ltd | -1.620% | -4.796% | -21.094% | -42.368% | -11.557% | -81.167% | -90.730% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by HC Wainwright from $110.00 to $120.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Leerink Partners from $102.00 to $104.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat